Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy

被引：42

作者：

Fisk, TL ^{[1
]}

Hon, HM

Lennox, JL

von Reyn, CF

Horsburgh, CR

机构：

[1] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA

[2] Grady Mem Hosp, Atlanta, GA USA

[3] Emory Univ, Sch Med, Atlanta, GA USA

[4] Dartmouth Hitchcock Med Ctr, Infect Dis Sect, Lebanon, NH 03766 USA

[5] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

来源：

AIDS | 2003年 / 17卷 / 07期

关键词：

D O I：

10.1097/00002030-200305020-00027

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This cross-sectional study of 110 individuals examined skin testing for latent tuberculosis infection (LTBI) after the initiation of highly active antiretroviral therapy. Skin test reactivity to one or more of four antigens was found in 98 out of 110 subjects (89%), and was maximal in those whose CD4 cell counts recovered to greater than or equal to100 cells/mm(3). Skin testing is reliable for the identification or exclusion of LTBI once the CD4 cell count recovers to greater than or equal to100 cells/mm(3).

引用

页码：1102 / 1104

页数：3

共 50 条

[21] Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV-infected patients - Natural history and clinical predictors
Lin, DY
Warren, JF
Lazzeroni, LC
Wolitz, RA
Mansour, SE
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2002, 22 (03): : 268 - 277
[22] Pruritus in HIV-infected patients in the era of highly active antiretroviral therapy
Blanes, Mar
Belinchon, Isabel
Betlloch, Isabel
Portilla, Joaquin
Reus, Sergio
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB119 - AB119
[23] Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy
Bernasconi, E
Uhr, M
Magenta, L
Ranno, A
Telenti, A
AIDS, 2001, 15 (08) : 1081 - 1082
[24] Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy
Foulon, G
Wislez, M
Naccache, JM
Blanc, FX
Rabbat, A
Israël-Biet, D
Valeyre, D
Mayaud, C
Cadranel, J
CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 418 - 425
[25] Hospitalized HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
Metsch, Lisa R.
Bell, Christine
Pereyra, Margaret
Cardenas, Gabriel
Sullivan, Tanisha
Rodriguez, Allan
Gooden, Lauren
Khoury, Nayla
Kuper, Tamy
Brewer, Toye
del Rio, Carlos
AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 (06) : 1045 - 1049
[26] Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients
Sendi, PP
Bucher, HC
Harr, T
Craig, BA
Schwietert, M
Pfluger, D
Gafni, A
Battegay, M
AIDS, 1999, 13 (09) : 1115 - 1122
[27] Cardiovascular disease in HIV-infected patients on highly active antiretroviral therapy
Jericó, C
Knobel, H
Carmona, A
Sorli, ML
López-Colomés, JL
Pedro-Botet, J
MEDICINA CLINICA, 2004, 122 (08): : 298 - 300
[28] Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients
Barbaro, G
Klatt, EC
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (18) : 1475 - 1481
[29] Autoimmune Diabetes in HIV-Infected Patients on Highly Active Antiretroviral Therapy
Takarabe, Daisuke
Rokukawa, Yuka
Takahashi, Yoshihiko
Goto, Atsushi
Takaichi, Maki
Okamoto, Masahide
Tsujimoto, Tetsuro
Noto, Hiroshi
Kishimoto, Miyako
Kaburagi, Yasushi
Yasuda, Kazuki
Yamamoto-Honda, Ritsuko
Tsukada, Kunihisa
Honda, Miwako
Teruya, Katsuji
Kajio, Hiroshi
Kikuchi, Yoshimi
Oka, Shinichi
Noda, Mitsuhiko
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (08): : 4056 - 4060
[30] Dyspepsia in HIV-infected patients under highly active antiretroviral therapy
Werneck-Silva, Ana Luiza
Prado, Ivete Bedin
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (11) : 1712 - 1716

← 1 2 3 4 5 →